{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:16:17Z","timestamp":1786979777310,"version":"build-2736575974"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T00:00:00Z","timestamp":1642118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T00:00:00Z","timestamp":1642118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s00213-021-06043-y","type":"journal-article","created":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T01:18:05Z","timestamp":1642123085000},"page":"1499-1507","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Effects of cannabidiol on symptoms induced by the recall of traumatic events in patients with posttraumatic stress disorder"],"prefix":"10.1007","volume":"239","author":[{"given":"L\u00edvia Maria","family":"Bolsoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Alexandre S.","family":"Crippa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime Eduardo Cec\u00edlio","family":"Hallak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Silveira","family":"Guimar\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Waldo","family":"Zuardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,14]]},"reference":[{"key":"6043_CR1","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association (APA). Diagnostic and statistical manual of mental disorders. 5th ed. S\u00e3o Paulo: Manole, 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"issue":"1","key":"6043_CR2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.31505\/rbtcc.v16i1.659","volume":"16","author":"AC Ara\u00fajo","year":"2014","unstructured":"Ara\u00fajo AC, Lotufo FN (2014) A nova classifica\u00e7\u00e3o Americana para os Transtornos Mentais: o Dsm-5. Rev Bras Ter Comport Cogn 16(1):67\u201382","journal-title":"Rev Bras Ter Comport Cogn"},{"key":"6043_CR3","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.phrs.2016.07.024","volume":"111","author":"A Berardi","year":"2016","unstructured":"Berardi A, Schelling G, Campolongo P (2016) The endocannabinoid system and Post Traumatic Stress Disorder (PTSD): from preclinical findings to innovative therapeutic approaches in clinical settings. Pharmacol Res 111:668\u2013678","journal-title":"Pharmacol Res"},{"issue":"6","key":"6043_CR4","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/npp.2011.6","volume":"36","author":"MM Bergamaschi","year":"2011","unstructured":"Bergamaschi MM, Queiroz RH, Chagas MHN, De Oliveira DCG, De Martinis BS, Kapczinski F, Quevedo J, Roesler R, Schroder N, Nardi AE, Martin-Santos R, Hallak JEC, Zuardi AW, Crippa JAS (2011) Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-na\u00efve social phobia patients. Neuropsychopharmacol 36(6):1219\u20131226","journal-title":"Neuropsychopharmacol"},{"issue":"3","key":"6043_CR5","first-page":"31","volume":"29","author":"AMP Biaggio","year":"1977","unstructured":"Biaggio AMP, Natal\u00edcio L, Spielberg C (1977) Desenvolvimento da forma experimental em portugu\u00eas do Invent\u00e1rio de Ansiedade Tra\u00e7o-Estado (IDATE) de Spielberger. Arq Bras Psic Apli 29(3):31\u201344","journal-title":"Arq Bras Psic Apli"},{"key":"6043_CR6","doi-asserted-by":"crossref","unstructured":"Binotto AL, Santos LL, Lourosa QL, Sant\u2019anna SC, Zanetti ACG, Marque JMA (2012) Interface sa\u00fade da fam\u00edlia & sa\u00fade mental: uma estrat\u00e9gia para o cuidado. Rev Bras Med Fam Comunidade 7(23), p.83\u201389","DOI":"10.5712\/rbmfc7(23)132"},{"key":"6043_CR7","doi-asserted-by":"publisher","first-page":"502","DOI":"10.3389\/fnins.2018.00502","volume":"12","author":"RM Bitencourt","year":"2018","unstructured":"Bitencourt RM, Takahashi RN (2018) Cannabidiol as a therapeutic alternative for post-traumatic stress disorder: from bench research to confirmation in human trials. Front Neurosci 12:502","journal-title":"Front Neurosci"},{"issue":"12","key":"6043_CR8","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.euroneuro.2008.07.001","volume":"18","author":"RM Bitencourt","year":"2008","unstructured":"Bitencourt RM, Pamplona FA, Takahashi RN (2008) Facilitation of contextual fear memory extinction and anti-anxiogenic effects of AM404 and cannabidiol in conditioned rats. Eur Neuropsychopharmacol 18(12):849\u2013859","journal-title":"Eur Neuropsychopharmacol"},{"issue":"4","key":"6043_CR9","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/sj.bjp.0704327","volume":"134","author":"T Bisogno","year":"2001","unstructured":"Bisogno T, Hanus L, De Petrocellis L et al (2001) Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide. Br J Pharmacol 134(4):845\u2013852","journal-title":"Br J Pharmacol"},{"issue":"11","key":"6043_CR10","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1016\/j.jpsychires.2012.08.012","volume":"46","author":"AC Campos","year":"2012","unstructured":"Campos AC, Ferreira FR, Guimar\u00e3es FS (2012) Cannabidiol blocks long- lasting behavioral consequences of predator threat stress: possible involvement of 5HT1A receptors. J Psychiatr Res 46(11):1501\u20131510","journal-title":"J Psychiatr Res"},{"issue":"21","key":"6043_CR11","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1017\/S109285291600016X","volume":"1","author":"L Carmi","year":"2016","unstructured":"Carmi L, Fostick L, Burshtein S, Cwikel-Hamzany S, Zohar J (2016) Ptsd treatment in light of DSM-5 and the \u201cgolden hours\u201d concept. Spectrums 1(21):279\u2013282","journal-title":"Spectrums"},{"issue":"Suppl1","key":"6043_CR12","first-page":"S56","volume":"32","author":"JAS Crippa","year":"2010","unstructured":"Crippa JAS, Zuardi AW, Hallak JEC (2010) Therapeutical use of the cannabinoids in psychiatry. Rev Bras Psiquiatr 32(Suppl1):S56-66","journal-title":"Rev Bras Psiquiatr"},{"issue":"4","key":"6043_CR13","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s00213-012-2955-y","volume":"226","author":"RK Das","year":"2013","unstructured":"Das RK, Kamboj SK, Ramadas M, Yogan K, Gupta V, Redman E, Curran HV, Morgan CJ (2013) Cannabidiol enhances consolidation of explicit fear extinction in humans. Psychopharmacology 226(4):781\u2013792","journal-title":"Psychopharmacology"},{"issue":"3","key":"6043_CR14","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1017\/S0033291700022352","volume":"21","author":"JR Davidson","year":"1991","unstructured":"Davidson JR, Hughes D, Blazer DG, George LK (1991) Post-traumatic stress disorder in the community: an epidemiological study. Psychol Med 21(3):713\u2013721","journal-title":"Psychol Med"},{"key":"#cr-split#-6043_CR15.1","doi-asserted-by":"crossref","unstructured":"Ehlers A, Clark DM (2000) A cognitive model of posttraumatic stress disorder. Behav Res Ther., v.38, n.4, p.319-345Einarsson, E.\u00d6.","DOI":"10.1016\/S0005-7967(99)00123-0"},{"key":"#cr-split#-6043_CR15.2","doi-asserted-by":"crossref","unstructured":"Nader, K. Involvement of the anterior cingulate cortex in formation, consolidation, and reconsolidation of recent and remote contextual fear memory. Learn Mem., v.19, n.10, p.449-452, 2012.","DOI":"10.1101\/lm.027227.112"},{"issue":"10","key":"6043_CR16","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1101\/lm.027227.112","volume":"19","author":"E\u00d6 Einarsson","year":"2012","unstructured":"Einarsson E\u00d6, Nader K (2012) Involvement of the anterior cingulate cortex in formation, consolidation, and reconsolidation of recent and remote contextual fear memory. Learn Mem 19(10):449\u2013452","journal-title":"Learn Mem"},{"key":"6043_CR17","unstructured":"First MB, Willians JBW, Karg RS, Spitzer RL (2017) Entrevista Cl\u00ednica e Estruturada para os transtornos do DSM-V \u2013 SCID-5 \u2013 CV. Porto Alegre: Artmed"},{"key":"6043_CR18","doi-asserted-by":"crossref","unstructured":"Gros Df, Price M, Magruder KM, Frueh BC (2012) Symptom overlap in posttraumatic stress disorder and major depression. Psychiatry Res., v.196, n. 2\u20133, p. 267\u2013270","DOI":"10.1016\/j.psychres.2011.10.022"},{"key":"6043_CR19","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1007\/BF02244012","volume":"100","author":"FS Guimar\u00e3es","year":"1990","unstructured":"Guimar\u00e3es FS, Chiaretti TM, Graeff FG, Zuardi AW (1990) Antianxiety effect of cannabidiol in the elevated plus-maze. Psychopharmacology 100:558\u2013559","journal-title":"Psychopharmacology"},{"issue":"3","key":"6043_CR20","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1037\/0022-006X.71.3.419","volume":"71","author":"SL Halligan","year":"2003","unstructured":"Halligan SL, Michael T, Clark DM, Ehlers A (2003) Posttraumatic stress disorder following assault: the role of cognitive processing, trauma memory, and appraisals. J Consult Clin Psychol 71(3):419\u2013431","journal-title":"J Consult Clin Psychol"},{"key":"6043_CR21","unstructured":"Janoff-Bulman R (1985) The aftermath of victimisation: rebuilding shattered assumptions. In C. R. Figley, Traumaand its wake: the study and treatment of posttraumatic stress disorder. New York: Brunner and Mazel. pp. 15\u201335"},{"issue":"25","key":"6043_CR22","doi-asserted-by":"publisher","first-page":"6677","DOI":"10.1523\/JNEUROSCI.0153-06.2006","volume":"26","author":"K Kamprath","year":"2006","unstructured":"Kamprath K, Marsicano G, Tang J, Monory K, Bisogno T, Di Marzo V, Lutz B, Wotjak CT (2006) Cannabinoid Cb1 receptor mediates fear extinction via habituation-like processes. J Neurosci 26(25):6677\u20136686","journal-title":"J Neurosci"},{"issue":"12","key":"6043_CR23","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1001\/archpsyc.1995.03950240066012","volume":"52","author":"RC Kessler","year":"1995","unstructured":"Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB (1995) Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry 52(12):1048\u20131060","journal-title":"Arch Gen Psychiatry"},{"issue":"6","key":"6043_CR24","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1001\/archpsyc.62.6.593","volume":"62","author":"RC Kessler","year":"2005","unstructured":"Kessler RC, Berglund P, Delmer O (2005) Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62(6):593\u2013602","journal-title":"Arch Gen Psychiatry"},{"key":"6043_CR25","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/01.psy.0000188566.35902.e7","volume":"68","author":"RTL Lindauer","year":"2006","unstructured":"Lindauer RTL, Van Meijel EPM, Jalink M, Olff M, Carlier IVE, Gersons BPR (2006) Heart rate responsivity to script-driven imagery in posttraumatic stress disorder: specificity of response and effects of psychotherapy. Psychosom Med 68:33\u201340","journal-title":"Psychosom Med"},{"issue":"1","key":"6043_CR26","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1590\/1516-4446-2017-0015","volume":"41","author":"IM Linares","year":"2019","unstructured":"Linares IM, Zuardi AW, Pereira LC, Queiroz RH, Mechoulam R, Guimar\u00e3es FS, Crippa JA (2019) Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test. Braz J Psychiatry 41(1):9\u201314","journal-title":"Braz J Psychiatry"},{"issue":"4","key":"6043_CR27","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1590\/S1677-54492011000400001","volume":"10","author":"HA Miot","year":"2011","unstructured":"Miot HA (2011) Sample size in clinical and experimental trials. J Vasc Bras 10(4):275\u2013278","journal-title":"J Vasc Bras"},{"issue":"5929","key":"6043_CR28","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1126\/science.1167975","volume":"324","author":"MH Monfils","year":"2009","unstructured":"Monfils MH, Cowansage KK, Klann E, Ledoux JE (2009) Extinction-reconsolidation boundaries: key to persistent attenuation of fear memories. Science 324(5929):951\u2013955","journal-title":"Science"},{"issue":"2","key":"6043_CR29","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/0028-3908(71)90039-6","volume":"10","author":"H Norris","year":"1971","unstructured":"Norris H (1971) The action of sedatives on brain stem oculomotor systems in man. Neuropharmacology 10(2):181\u2013191","journal-title":"Neuropharmacology"},{"key":"6043_CR30","doi-asserted-by":"crossref","unstructured":"Os\u00f3rio FL, Silva TDA, Santos RG, Hortes M, Chagas N, Chagas NM, Sanches Rf, Crippa JAS (2019) Posttraumatic stress disorder checklist for DSM-5 (PCL-5): transcultural adaptation of the Brazilian version. Arch Clin Psychiatry., v. 44, n.1, p.10\u201319","DOI":"10.1590\/0101-60830000000107"},{"key":"6043_CR31","doi-asserted-by":"crossref","unstructured":"Os\u00f3rio FL, Loureiro SR, Hallak JEC, Machado-De-Sousa JP, Ushirohira JM, Baes CVW, et al. (2019) Clinical validity and intrarater and test-retest reliability of the Structured Clinical Interview for DSM-5 - Clinician Version (SCID-5-CV). Psychiatry Clin Neurosci, v.73, n.12, p.754\u2013760","DOI":"10.1111\/pcn.12931"},{"issue":"1-2","key":"6043_CR32","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.neulet.2005.12.026","volume":"397","author":"FA Pamplona","year":"2006","unstructured":"Pamplona FA, Takahashi RN (2006) Win 55212\u20132 impairs contextual fear conditioning through the activation of CB1 cannabinoid receptors. Neurosci Lett 397(1\u20132):88\u201392","journal-title":"Neurosci Lett"},{"issue":"6","key":"6043_CR33","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.euroneuro.2005.05.002","volume":"15","author":"ACBV Parente","year":"2005","unstructured":"Parente ACBV, Garcia-Leal C, Del-Bem CM, Guimar\u00e3es FS, Graeff FG (2005) Subjective and neurovegetative changes in health volunteers and panic patients performing simulated public speaking. Eur Neuropsychopharmacol 15(6):663\u2013671","journal-title":"Eur Neuropsychopharmacol"},{"issue":"2","key":"6043_CR34","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0006-3223(01)01279-3","volume":"51","author":"R Pitman","year":"2002","unstructured":"Pitman R, Sanders K, Zusman R (2002) Pilot study of secondary prevention of posttraumatic stress disorder with propranolol. Biol Psychiatry 51(2):189\u2013192","journal-title":"Biol Psychiatry"},{"issue":"7277","key":"6043_CR35","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nature08637","volume":"463","author":"D Schiller","year":"2010","unstructured":"Schiller D, Monfils MH, Raio CM, Johnson DC, Ledoux JE, Phelps EA (2010) Preventing the return of fear in humans using reconsolidation update mechanisms. Nature 463(7277):49\u201353","journal-title":"Nature"},{"issue":"24","key":"6043_CR36","first-page":"5","volume":"5","author":"D Schiller","year":"2011","unstructured":"Schiller D, Phelps EA (2011) Does reconsolidation occur in humans? Front Behav Neurosci 5(24):5\u201324","journal-title":"Front Behav Neurosci"},{"key":"6043_CR37","doi-asserted-by":"crossref","unstructured":"Shalev AY, Freedman S, Peri T, Brandes D, Sahar T, Orr Sp and others (1998) Prospective study of posttraumatic stress disorder and depression following trauma. Am J Psychiatry., v.155, p.630\u2013637","DOI":"10.1176\/ajp.155.5.630"},{"key":"6043_CR38","volume-title":"Manual for state-trait anxiety inventory","author":"CD Spielberger","year":"1970","unstructured":"Spielberger CD, Gorsuch RL, Lushene RE (1970) Manual for state-trait anxiety inventory. Consulting Psychologist Press, Palo Alto, CA"},{"issue":"9","key":"6043_CR39","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1038\/npp.2012.63","volume":"37","author":"CA Stern","year":"2012","unstructured":"Stern CA, Gazarini L, Takahashi RN, Guimar\u00e3es FS, Bertoglio LJ (2012) On disruption of fear memory by reconsolidation blockade: evidence from cannabidiol treatment. Neuropsychopharmacology 37(9):2132\u20132142","journal-title":"Neuropsychopharmacology"},{"key":"6043_CR40","doi-asserted-by":"crossref","unstructured":"Stern CA, Gazarini L, Vanxossen AC, Zuardi AW, Guimar\u00e3es FS, Takahashi RN, Bertoglio LJ (2014) Involvement of the prelimbic cortex in the disruptive effect of cannabidiol on fear memory reconsolidation. 27th ECNP Congress","DOI":"10.1016\/S0924-977X(14)70511-5"},{"issue":"6","key":"6043_CR41","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.euroneuro.2015.02.001","volume":"25","author":"CA Stern","year":"2015","unstructured":"Stern CA, Gazarini L, Vanvossen AC, Zuardi AW, Galve-Roperh I, Guimaraes FS, Takahashi RN, Bertoglio LJ (2015) \u03949-Tetrahydrocannabinol alone and combined with cannabidiol mitigate fear memory through reconsolidation disruption. Eur Neuropsychopharmacol 25(6):958\u2013965","journal-title":"Eur Neuropsychopharmacol"},{"key":"6043_CR42","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.neuropharm.2017.07.024","volume":"125","author":"CAJ Stern","year":"2017","unstructured":"Stern CAJ, Da Silva TR, Raymundi AM, De Souza CP, Hiroaki-Sato VA, Kato L, Guimar\u00e3es FS, Andreatini R, Takahashi RN, Bertoglio LJ (2017) Cannabidiol disrupts the consolidation of specific and generalized fear memories via dorsal hippocampus CB1 and CB2 receptors. Neuropharmacology 125:220\u2013230","journal-title":"Neuropharmacology"},{"issue":"3","key":"6043_CR43","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s11920-015-0549-1","volume":"17","author":"A Van Minnen","year":"2015","unstructured":"Van Minnen A, Zoellner LA, Harned MS, Mills K (2015) Changes in comorbid conditions after prolonged exposure for PTSD: a literature review. Curr Psychiatry Rep 17(3):549","journal-title":"Curr Psychiatry Rep"},{"key":"6043_CR44","unstructured":"Weathers FW, Litz BT, Keane TM, Palmieri PA, Marx BP, Schnurr PP (2013) The PTSD Checklist for DSM-5 (PCL-5) [Internet]. 2013 [2018 Apr 2]. Available from: https:\/\/www.ptsd.va.gov\/professional\/assessment\/adult-sr\/ptsd-checklist.asp"},{"key":"6043_CR45","doi-asserted-by":"crossref","unstructured":"Wolf SA, Bick-Sander A, Fabel K, Leal-Galicia P, Tauber S, Ramirez-Rodriguez G, et al. (2010) Cannabinoid receptor Cb1 mediates baseline and activity-induced survival of new neurons in adult hippocampal neurogenesis. Cell Commun Signal, v. 8, n. 12","DOI":"10.1186\/1478-811X-8-12"},{"issue":"5","key":"6043_CR46","first-page":"403","volume":"30","author":"AW Zuardi","year":"1981","unstructured":"Zuardi AW, Karniol IG (1981) Estudo transcultural de uma escala de auto-avalia\u00e7\u00e3o para estados subjetivos. J Bras Psiquiatr 30(5):403\u2013406","journal-title":"J Bras Psiquiatr"},{"key":"6043_CR47","doi-asserted-by":"crossref","unstructured":"Zuardi AW, Shirakawa I, Finkelfarb E, Karniol IG (1982) Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects. Psychopharmacology (Berl). v.76, n.3, p.245\u2013250","DOI":"10.1007\/BF00432554"},{"key":"6043_CR48","doi-asserted-by":"crossref","unstructured":"Zuardi AW, Cosme RA, Graeff FG, Guimar\u00e3es FS (1993) Effects of ipsapirone and cannabidiol on human experimental anxiety. J Psychopharmacol., v.7 (1Suppl), p.82\u201388","DOI":"10.1177\/026988119300700112"},{"key":"6043_CR49","doi-asserted-by":"crossref","unstructured":"Zuardi AW, Crippa JAS, Hallak JEC, Campos AC, Guimar\u00e3es FS (2017a) The anxiolytic effects of cannabidiol. In: Handbook of cannabis and related pathologies, V Preedy (Ed). Academic Press: e131-e139","DOI":"10.1016\/B978-0-12-800756-3.00097-1"},{"issue":"8","key":"6043_CR50","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3389\/fphar.2017.00259","volume":"11","author":"AW Zuardi","year":"2017","unstructured":"Zuardi AW, Rodrigues NP, Silva AL, Bernardo SA, Hallak JEC, Guimar\u00e3es FS, Crippa JAS (2017b) Inverted U-shaped dose-response curve of the anxiolytic effect of cannabidiol during public speaking in real life. Front Pharmacol 11(8):259","journal-title":"Front Pharmacol"},{"issue":"3","key":"6043_CR51","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1590\/S1516-44462008000300015","volume":"30","author":"AW Zuardi","year":"2008","unstructured":"Zuardi AW (2008) Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action. Braz J Psychiatry 30(3):271\u2013280","journal-title":"Braz J Psychiatry"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-021-06043-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-021-06043-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-021-06043-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T15:52:52Z","timestamp":1700063572000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-021-06043-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,14]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["6043"],"URL":"https:\/\/doi.org\/10.1007\/s00213-021-06043-y","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,14]]},"assertion":[{"value":"13 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"JAC, JEH, and AWZ are coinventors of the patent \u201cFluorinated CBD compounds, compositions and uses thereof. Pub. No.: WO\/2014\/108899. International Application No.: PCT\/IL2014\/050023,\u201d Def. US number Reg. 62193296; July 29, 2015; INPI on August 19, 2015 (BR1120150164927; Mechoulam R, Zuardi AW, Kapczinski F, Hallak JEC, Guimar\u00e3es FS, Crippa JAS, Breuer A). Universidade de S\u00e3o Paulo (USP) has licensed this patent to Phytecs Pharm (USP Resolution No. 15.1.130002.1.1) and has an agreement with Prati-Donaduzzi to \u201cdevelop a pharmaceutical product containing synthetic CBD and prove its safety and therapeutic efficacy in the treatment of epilepsy, schizophrenia, Parkinson\u2019s disease, and anxiety disorders.\u201d JAC, JEH, and AWZ are coinventors of the patent \u201cCannabinoid-containing oral pharmaceutical composition, method for preparing and using same,\u201d INPI on September 16th, 2016 (BR 112018005423\u20132). JASC is a consultant and\/or has received speaker fees and\/or sits on the advisory board and\/or receives research funding from Janssen-Cilag, Torrent Pharm, Prati-Donaduzzi, PurMed Global, BSPG Pharm, and the Australian Centre for Cannabinoid Clinical and Research Excellence (ACRE) \u2013 National Health and Medical Research Council (NHMRC) over the past 3\u00a0years. JEH was a consultant from BSPG-Pharm and PurMed Global over the past 3\u00a0years. The other authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}